DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation (OTCBB: CONX), a worldwide developer and marketer of diagnostic test kits, today filed its 2nd quarter Form 10-QSB and reported financial results. The report disclosed that the company’s sales and operating results have advanced during the quarter and six months ended December 31, 2007, and further confirmed that the initiatives the company put in place several months earlier are proving very effective. Some of the results highlighted by the report are as follows:
